Amgen Inc.
Biotechnology / BiopharmaceuticalsFounded 1980- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
Amgen Inc.
Annual Revenue
Last reviewed: 2025-07-15 · By Swet Parvadiya
FY2022 Revenue
$26.3B
▲ 1.3% vs FY2021 ($26.0B)
Amgen Inc. reported $26.3B in revenue for fiscal year 2022. This represents a growth of 1.3% compared to the 2021 figure of $26.0B. In 2023, revenue increased to $28.2B.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $33.4B | $3.8B | +18.6% |
| FY2023 | $28.2B | — | +7.1% |
| FY2022 | $26.3B | — | +1.3% |
| FY2021 | $26.0B | — | +2.2% |
| FY2020 | $25.4B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.